World's Best Scientists 2026 revealed!
Award Badge
Best Scientists
2025
Award Badge
Immunology
USA
2026

D-Index & Metrics

Best Scientists

D-Index
256
Citations
288412
World Ranking
42
National Ranking
27

Immunology

D-Index
260
Citations
292522
World Ranking
3
National Ranking
2

Medicine

D-Index
263
Citations
295948
World Ranking
24
National Ranking
18

Steven A. Rosenberg publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Steven A. Rosenberg sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 1,251 publications — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Steven A. Rosenberg D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Steven A. Rosenberg sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 260 D-Index — 100th percentile

100% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2026 - Research.com Immunology in United States Leader Award
  • 2026 - Research.com Medicine in United States Leader Award
  • 2025 - Research.com Best Scientists Award
  • 2025 - Research.com Immunology in United States Leader Award
  • 2025 - Research.com Medicine in United States Leader Award
  • 2023 - Research.com Medicine in United States Leader Award
  • 2022 - Research.com Immunology in United States Leader Award
  • 2019 - Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR)
  • 2019 - AAI-Steinman Award for Human Immunology Research, American Association of Immunologists
  • 2018 - Albany Medical Center Prize in Medicine and Biomedical Research
  • 2012 - Keio Medical Science Prize, Keio University, Tokyo, Japan
  • 2010 - Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB)
  • 1987 - Member of the National Academy of Medicine (NAM)

Overview

Steven A. Rosenberg is affiliated with the National Institutes of Health in the United States. Their research predominantly focuses on Medicine and Immunology and Microbiology, with subfields including Oncology, Immunology, Molecular Biology, Genetics, and Electrical and Electronic Engineering.

The main topics covered in their work are:

  • CAR-T cell therapy research
  • Immunotherapy and Immune Responses
  • Cancer Immunotherapy and Biomarkers
  • Immune Cell Function and Interaction
  • Virus-based gene therapy research
  • Vaccines and immunoinformatics approaches
  • T-cell and B-cell Immunology

Frequent co-authors collaborating with Steven A. Rosenberg include:

  • Frank J. Lowery
  • Paul F. Robbins
  • Jared J. Gartner
  • Stephanie L. Goff
  • Maria R. Parkhurst

Notable publication venues where Rosenberg has frequently contributed are:

  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • Cancer Research
  • Nature Medicine
  • Cancer Cell

Significant recent papers include:

  • "Stem-like CD8 T cells mediate response of adoptive cell immunotherapy against human cancer," 2020, Science
  • "Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer," 2022, New England Journal of Medicine
  • "Molecular signatures of antitumor neoantigen-reactive T cells from metastatic human cancers," 2022, Science
  • "Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors," 2020, Cancer Cell
  • "mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer," 2020, Journal of Clinical Investigation

Several awards have been conferred on Steven A. Rosenberg throughout their career, including:

  • Szent-Györgyi Prize for Progress in Cancer Research, National Foundation for Cancer Research (NFCR), 2019
  • AAI-Steinman Award for Human Immunology Research, American Association of Immunologists, 2019
  • Albany Medical Center Prize in Medicine and Biomedical Research, 2018
  • Keio Medical Science Prize, Keio University, Tokyo, Japan, 2012
  • Karl Landsteiner Memorial Award, American Association of Blood Banks (AABB), 2010
  • Member of the National Academy of Medicine (NAM), 1987

Best Publications

  • Cancer : Principles and Practice of Oncology

    Vincent T. DeVita;Samuel Hellman;Steven A. Rosenberg

  • Cancer regression in patients after transfer of genetically engineered lymphocytes

    Richard A. Morgan;Mark E. Dudley;John R. Wunderlich;Marybeth S. Hughes

  • Cancer immunotherapy: moving beyond current vaccines.

    Steven A Rosenberg;James C Yang;Nicholas P Restifo

  • Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes

    Mark E. Dudley;John R. Wunderlich;Paul F. Robbins;James C. Yang

  • A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Alfred E. Chang

  • A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer

    James C. Yang;Leah Haworth;Richard M. Sherry;Patrick Hwu

  • Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic Cancer

    Steven A. Rosenberg;Michael T. Lotze;Linda M. Muul;Susan Leitman

  • Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report.

    S A Rosenberg;B S Packard;P M Aebersold;D Solomon

  • T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial

    Daniel W Lee;James N Kochenderfer;Maryalice Stetler-Stevenson;Yongzhi K Cui

  • Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2

    Richard A Morgan;James C Yang;Mio Kitano;Mark E Dudley

  • Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.

    Elizabeth A Grimm;A. Mazumder;H. Z. Zhang;S. A. Rosenberg

  • Adoptive cell transfer as personalized immunotherapy for human cancer.

    Steven A. Rosenberg;Nicholas P. Restifo

  • Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T Cell Transfer Immunotherapy

    Steven A. Rosenberg;James C. Yang;Richard M. Sherry;Udai S. Kammula

  • A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

    Steven A. Rosenberg;Paul Spiess;Rene Lafreniere

  • High-Dose Recombinant Interleukin 2 Therapy for Patients With Metastatic Melanoma: Analysis of 270 Patients Treated Between 1985 and 1993

    Michael B. Atkins;Michael T. Lotze;Janice P. Dutcher;Richard I. Fisher

  • Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer

    Eric Tran;Simon Turcotte;Alena Gros;Paul F. Robbins

  • Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma

    Steven A. Rosenberg;James C. Yang;Douglas J. Schwartzentruber;Patrick Hwu

  • T Lymphocyte-Directed Gene Therapy for ADA− SCID: Initial Trial Results After 4 Years

    R. Michael Blaese;Kenneth W. Culver;A. Dusty Miller;Charles S. Carter

  • Adoptive cell transfer: a clinical path to effective cancer immunotherapy

    Steven A. Rosenberg;Nicholas P. Restifo;James C. Yang;Richard A. Morgan

  • Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma

    Mark E. Dudley;John R. Wunderlich;James C. Yang;Richard M. Sherry

Frequent Co-Authors

Nicholas P. Restifo
Nicholas P. Restifo National Institutes of Health
James Chih-Hsin Yang
James Chih-Hsin Yang National Taiwan University
Paul F. Robbins
Paul F. Robbins National Cancer Institute
Richard A. Morgan
Richard A. Morgan University of California, Los Angeles
Mark E. Dudley
Mark E. Dudley Novartis (Switzerland)
Suzanne L. Topalian
Suzanne L. Topalian Johns Hopkins University
John R. Wunderlich
John R. Wunderlich National Institutes of Health
James J. Mulé
James J. Mulé University of South Florida
Seth M. Steinberg
Seth M. Steinberg National Institutes of Health
Maria R. Parkhurst
Maria R. Parkhurst National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Immunology often intersects with various healthcare fields, including nursing and mental health. For those interested in complementary pathways, understanding which programs are accessible is crucial. For example, prospective students can find valuable insights on which LPN programs are easiest to get into, helping them start their clinical careers efficiently.

Similarly, nursing professionals may consider advancing through Nurse Practitioner roles. Information on the easiest NP programs to get into can guide applicants seeking streamlined admission processes.

Mental health specialization is another relevant avenue. Online PMHNP programs with strong support systems enhance clinical experience, and resources highlighting online PMHNP programs with clinical placement offer key information for those wanting hands-on learning opportunities.

Cost often remains a major consideration. Students looking for affordable options can explore comprehensive lists of the cheapest psych NP programs to balance budget with quality education.

By reviewing these resources, immunology students and healthcare professionals alike can make informed decisions about advancing their education and careers in related fields.

Best Scientists Citing Steven A. Rosenberg

Trending Scientists

Recently Published Articles